Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus.

27 Similarly, an exploratory continuous glucose-monitoring study reported lower within- and between-day variability with Gla-300 vs Gla-100, although these differences did not reach statistical significance. 29 Results from multiple-dose studies were consistent with other single-dose studies performed in people with T1DM.

also in 111,027 other papers